Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengqing Jiangzhuo capsule
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shengqing Jiangzhuo capsule (SQJZ) is a traditional Chinese medicine prescription that has demonstrated potential in alleviating chronic kidney disease (CKD) and diabetic nephropathy (DN). It is a compound capsule, with Quercetin identified as one of its main components. In CKD, SQJZ alleviates intestinal inflammation by downregulating CHAC glutathione-specific γ-glutamylcyclotransferase 1 (CHAC1) and subsequently inactivating the hypoxia-inducible factor 1 (HIF-1) pathway. For diabetic nephropathy, it exerts protective effects by activating the Keap1/Nrf2/ARE signaling pathway. Additionally, it has been shown to alleviate chronic renal failure symptoms by inhibiting the PI3k/Akt pathway, specifically by targeting PIK3R1, and by regulating the expression of NLRP3, caspase1, AQP1, and AQP2.
- Other names
- Shengqing JiangzhuoShengqing Jiangzhuo颗粒
02
Targets
KEAP1 (Kelch-like ECH-associated protein 1)CHAC1 (Glutathione-specific gamma-glutamylcyclotransferase 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)
Beyond the preview
Go deeper on Shengqing Jiangzhuo capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengqing Jiangzhuo capsule.